Clinical Information
patient
|
XJ201482 |
Age
|
69 |
Gender
|
M |
Genotype
|
HBV_gtC,HBV_gtE,HBV_gtD |
Diagnosis
|
hepatocellular carcinoma |
HBV DNA
|
<50 |
HBeAg
|
0 |
AFP(ng/ml)
|
17.9 |
PLT(log IU/mL)
|
208 |
HBcAb
|
1 |
HBsAb
|
0 |
HBeAb
|
0 |
HBsAg
|
1 |
ctDNA concentration
|
0.002725 |
marker
|
ctDNA- |
Hospital
|
Eastern Hepatobiliary Surgery Hospital, Shanghai |
HBsAg (IU/ml)
|
49.53 |
BCLC
|
C |
ACJJ
|
II |
Tumor maximum size
|
3 |
Tumor count
|
1 |
MVI
|
M1 |
AFP-L3
|
42.2 |
PIVKA-II (mAU/ml)
|
99 |
CA199 (U/ml)
|
23.8 |
Cirrhosis history
|
1 |
Fatty liver
|
0 |
Hepatic encephalopathy (1-3)
|
1 |
Ascites (1-3)
|
1 |
TBIL (μmol/L)
|
1 |
ALB (g/L)
|
1 |
INR
|
1 |
Score
|
5 |
Child-Pugh stage
|
A |
HBV integration detection
|
Yes |
Integration number
|
1 |
HBV subtype frequency
|
0.364399664147775,0.183879093198992,0.439126784214945 |
|
|